Cerus (CERS) Change in Account Payables (2010 - 2026)
Cerus (CERS) reported Change in Account Payables of $4.1 million for Q1 2026, down 17.79% on a YoY basis from $5.0 million in Q1 2025, and up 75.24% sequentially from $2.4 million in Q4 2025.
Cerus (CERS) Change in Account Payables (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Change in Account Payables data on file, last reported at $4.1 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 17.79% year-over-year to $4.1 million; the trailing twelve-month figure through Mar 2026 stood at $4.8 million (down 50.21% YoY), and the FY2025 full-year result was $5.7 million, up 487.61% from the prior year.
- Change in Account Payables grew to $4.1 million in Q1 2026, from $2.4 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $6.3 million in Q4 2024 to a low of -$15.4 million in Q4 2023.
- A 5-year average of -$226529.4 and a median of $643000.0 in 2022 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables sank 3416.99% in 2023 and surged 510.69% in 2025, its largest moves.
- Tracing CERS's Change in Account Payables over 5 years: stood at $465000.0 in 2022, then slumped by 3416.99% to -$15.4 million in 2023, then surged by 141.16% to $6.3 million in 2024, then slumped by 62.78% to $2.4 million in 2025, then jumped by 75.24% to $4.1 million in 2026.
- Business Quant data shows CERS's Change in Account Payables at $4.1 million in Q1 2026, $2.4 million in Q4 2025, and -$4.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 221.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn | 4.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.14 Mn |
| Mar 31, 2026 | 4.14 Mn |
| Dec 31, 2025 | 2.36 Mn |
| Dec 31, 2025 | 2.36 Mn |
| Sep 30, 2025 | -4.48 Mn |
| Sep 30, 2025 | -4.48 Mn |
| Jun 30, 2025 | 2.81 Mn |
| Jun 30, 2025 | 2.81 Mn |
| Mar 31, 2025 | 5.04 Mn |
| Mar 31, 2025 | 5.04 Mn |
| Dec 31, 2024 | 6.35 Mn |
| Dec 31, 2024 | 6.35 Mn |
| Sep 30, 2024 | -1.00 Mn |
| Sep 30, 2024 | -1.00 Mn |
| Jun 30, 2024 | -683,000.00 |
| Jun 30, 2024 | -683,000.00 |
| Mar 31, 2024 | -6.14 Mn |
| Mar 31, 2024 | -6.14 Mn |
| Dec 31, 2023 | -15.42 Mn |
| Dec 31, 2023 | -15.42 Mn |